Myasthenic syndrome induced by D-penicillamine. Danger of curarization
Blanloeil, Y.; Baron, D.; Nicolas, F.
La Nouvelle Presse Medicale 9(48): 3695-3696
1980
ISSN/ISBN: 0301-1518 PMID: 6450409 Document Number: 154571
Document emailed within 1 workday
Related Documents
Tellkamp, F.; Kunath, B. 1984: Myasthenic syndrome--complication of D-penicillamine therapy Zeitschrift für Arztliche Fortbildung 78(11): 439-442Oroszlán, G.; Sanderud, J.; Saugstad, O.D.; Lakatos, L. 1992: D-penicillamine: old drug, new indication? D-penicillamine reduced pulmonary hypertension induced by free radicals Orvosi Hetilap 133(44): 2835-2836; 2839
Derk, C.T.; Jimenez, S.A. 2003: Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature Journal of Rheumatology 30(7): 1616-1620
Kaeser, H.E. 1993: What is your diagnosis? Lambert-Eaton myasthenic syndrome Schweizerische Rundschau für Medizin Praxis 82(34): 897-898
Lobzin, V.S.; Kosachev, V.D.; Sidorova, T.G.; Rudenko, D.I. 1990: Lambert-Eaton myasthenic syndrome in bronchogenic carcinoma Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(9): 91-94
Azulay, J.P.; Pouget, J.; Figarella-Branger, D.; Colamarino, R.; Pellissier, J.F.; Serratrice, G. 1994: Isolated proximal muscular weakness disclosing myasthenic syndrome Revue Neurologique (Paris) 150(5): 377-381
De Zanche, L.; Fardin, P.; Busnardo, B. 1974: Anatomo-clinical study of a case of myasthenic syndrome with hyperthyroidism Rivista di Patologia Nervosa E Mentale 95(3): 134-140
Iqbal, M.; Connolly, S.; Langan, Y.; Redmond, J. 2012: A case of Lambert-Eaton myasthenic syndrome with possible myasthenia gravis Irish Medical Journal 105(6): 183-184
Guevara, C.; Pedraza, L.; Idiáquez, J.; Delgado, M. 2006: Idiopathic Lambert-Eaton myasthenic syndrome: report of one case Revista Medica de Chile 134(2): 217-222
Shipley, E.; Krim, E.; Deminiere, C.; Lagueny, A. 2008: Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma Revue Neurologique (Paris) 164(1): 72-76
Engel, A.G.; Lambert, E.H. 1978: Structure-function correlations in myasthenia gravis and a new myasthenic syndrome Electroencephalography and Clinical Neurophysiology. Suppl 34: 469-477
Reysalmon, C.; Messerschmitt, P. 2003: Maltraitance et enfants en danger protection maternelle et infantile. 1re Partie : Maltraitance et enfants en danger - Child abuse and children in danger la Revue du Praticien (Paris) 53(10): 1121-1127
Gieron, M.A.; Korthals, J.K.; Lewis, J.A. 1987: Lambert-Eaton myasthenic syndrome associated with hypothyroidism and features of myasthenia gravis Journal of the Florida Medical Association 74(5): 336-338
Nakashima, I.; Kikuchi, A.; Onodera, J.; Shiga, Y.; Fujihara, K.; Motomura, M.; Itoyama, Y. 1997: A juvenile case of Lambert-Eaton myasthenic syndrome with severe emaciation Rinsho Shinkeigaku 37(5): 402-406
Eymard, B. 1989: Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts Annales de Medecine Interne 140(6): 462-466
Lorenzoni, P.José.; Kay, Cáudia.Suely.Kamoi.; Arruda, W.Oleschko.; Scola, R.Herminia.; Werneck, L.César. 2006: Neurophysiological study in slow-channel congenital myasthenic syndrome: case report Arquivos de Neuro-Psiquiatria 64(2a): 318-321
Mitomo, H.; Tabata, T.; Sugawara, T.; Miyamoto, A.; Fujimura, S.; Murakami, K. 2014: Resected thymic hyperplasia with myasthenia gravis and Lambert-Eaton myasthenic syndrome Kyobu Geka. Japanese Journal of Thoracic Surgery 67(3): 194-197
Renier, J.C.; Masson, C.; Audran, M.; Rousselet, C.; Simard, C.; Saint-Andre, J.P. 1984: Polymyositis induced by D-penicillamine Therapie 39(6): 697-703
Sternlieb, I.; Fisher, M.; Scheinberg, I.H. 1981: Penicillamine-induced skin lesions Journal of Rheumatology. Suppl 7: 149-154
Haberhauer, G. 1989: D-penicillamine (DPA)-induced anticentromere antibody (ACA) Clinical and Experimental Rheumatology 7(3): 332-334